Weitz & Luxenberg is no longer accepting Heparin cases
Heparin Recall Import Alert: The FDA’s Role
Heparin, including the Active Pharmaceutical Ingredient (API) and finished heparin, enter U.S. ports from overseas.
The FDA issues an import alert on shipments from specified manufacturer(s) and product(s). If a product is imported from a manufacturer, investigators will detain the shipment.
Industry and FDA Response:
If the industry provides information and the FDA confirms that appropriate corrections have been made, the FDA will remove the manufacturer and product from the import alert.
Safe Product Alert:
The FDA continues to engage with industry to help ensure adequate supply of safe heparin reaches patients.
For additional information from the FDA, click here.
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
FDA: Analyzing the Contaminant Recall Alert: FDA Process of Analyzing Heparin Contaminant--Legal Info
Recall in the News: How the FDA Analyzes the Contaminant in Heparin
FDA Import Alert FDA Document on How it Monitors the import of Heparin--Free Legal Info
Information on How FDA monitors Heparin Drug Import--Lawsuit Review
Heparin Warning Letter FDA Warning Letter Sent to Heparin Plant Changzhou SPL Company
Warning letter cites dangerous practices that led to heparin injuries